Albion Financial Group Illumina, Inc. Transaction History

Albion Financial Group

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$181.58 - $368.0 $726 - $1,472	-4 Reduced 57.14%	3 $1,000
Q1 2022 May 09, 2022	BUY	$303.87 - $423.8 $303 - $423	1 Added 16.67%	7 $2,000
Q4 2021 Feb 15, 2022	BUY	$347.28 - $421.83 $2,083 - $2,530	6 New	6 $2,000
Q2 2021 Aug 12, 2021	SELL	$372.84 - $481.5 $19,760 - $25,519	-53 Closed	0 $0
Q4 2020 Feb 19, 2021	BUY	$292.7 - $370.96 $15,513 - $19,660	53 New	53 $20,000
Q3 2020 Nov 13, 2020	SELL	$268.51 - $400.74 $185,808 - $277,312	-692 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$256.46 - $373.01 $18,978 - $27,602	-74 Reduced 9.66%	692 $256,000
Q4 2019 Jan 31, 2020	SELL	$288.29 - $335.49 $288 - $335	-1 Reduced 0.13%	766 $254,000
Q2 2019 Aug 08, 2019	BUY	$300.59 - $368.15 $230,552 - $282,371	767 New	767 $282,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

Stay updated on Albion Financial Group with notifications on news.